Agathisflavone isolated from Anacardium occidentale suppresses SIRT1‐mediated neuroinflammation in BV2 microglia and neurotoxicity in APPSwe‐transfected SH‐SY5Y cells

Ravikanth Velagapudi, Olusiji Ajileye, Uchechukwu P. Okorji, Priya Jain, Mutallib Aderogba, Olumayokun Olajide

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Agathisflavone is a bioactive compound in Anacardium occidentale. In this study, we investigated inhibition neuroinflammation in BV2 microglia by agathisflavone. Neuroprotective activity of the compound was investigated in differentiated SH‐SY5Y cells. Experiments in lipopolysaccharide (LPS)‐activated BV2 microglia showed that pretreatment with agathisflavone (5–20 μM) produced significant reduction in the release of tumour necrosis factor‐α, interleukin‐6, interleukin‐1β, NO, and PGE2 from the cells. Immunoblotting experiments also revealed that agathisflavone reduced levels of iNOS and COX‐2 protein. Further studies revealed that agathisflavone reduced neuroinflammation by targeting critical steps in NF‐κB signalling in BV2 microglia. Treatment of SH‐SY5Y cells with conditioned medium from LPS‐activated BV2 microglia produced a significant reduction in neuronal viability. However, conditioned medium from BV2 cells that were stimulated with LPS in the presence of agathisflavone did not induce neurotoxicity. Agathisflavone also produced neuroprotection in APPSwe plasmid‐transfected SH‐SY5Y neurons. The compound further attenuated LPS‐induced and APPSwe plasmid‐induced reduction in SIRT1 in BV2 microglia and SH‐SY5Y, respectively. In the presence of EX527, agathisflavone lost its anti‐inflammatory and neuroprotective activities. Our results suggest that agathisflavone inhibits neuroinflammation in BV2 microglia by targeting NF‐κB signalling pathway. The compound also reduces neurotoxicity through mechanisms that are possibly linked to SIRT1 in the microglia and neurons
LanguageEnglish
Pages1957-1966
Number of pages10
JournalPhytotherapy Research
Volume32
Issue number10
Early online date22 May 2018
DOIs
Publication statusPublished - Oct 2018

Fingerprint

Anacardium
Microglia
Lipopolysaccharides
Conditioned Culture Medium
Plasmids
agathisflavone
Neurons
Interleukin-1beta
Dinoprostone
Immunoblotting
Interleukin-6
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha

Cite this

Velagapudi, Ravikanth ; Ajileye, Olusiji ; Okorji, Uchechukwu P. ; Jain, Priya ; Aderogba, Mutallib ; Olajide, Olumayokun. / Agathisflavone isolated from Anacardium occidentale suppresses SIRT1‐mediated neuroinflammation in BV2 microglia and neurotoxicity in APPSwe‐transfected SH‐SY5Y cells. In: Phytotherapy Research. 2018 ; Vol. 32, No. 10. pp. 1957-1966.
@article{16d9b1fe2b514882aeaee02c194e6775,
title = "Agathisflavone isolated from Anacardium occidentale suppresses SIRT1‐mediated neuroinflammation in BV2 microglia and neurotoxicity in APPSwe‐transfected SH‐SY5Y cells",
abstract = "Agathisflavone is a bioactive compound in Anacardium occidentale. In this study, we investigated inhibition neuroinflammation in BV2 microglia by agathisflavone. Neuroprotective activity of the compound was investigated in differentiated SH‐SY5Y cells. Experiments in lipopolysaccharide (LPS)‐activated BV2 microglia showed that pretreatment with agathisflavone (5–20 μM) produced significant reduction in the release of tumour necrosis factor‐α, interleukin‐6, interleukin‐1β, NO, and PGE2 from the cells. Immunoblotting experiments also revealed that agathisflavone reduced levels of iNOS and COX‐2 protein. Further studies revealed that agathisflavone reduced neuroinflammation by targeting critical steps in NF‐κB signalling in BV2 microglia. Treatment of SH‐SY5Y cells with conditioned medium from LPS‐activated BV2 microglia produced a significant reduction in neuronal viability. However, conditioned medium from BV2 cells that were stimulated with LPS in the presence of agathisflavone did not induce neurotoxicity. Agathisflavone also produced neuroprotection in APPSwe plasmid‐transfected SH‐SY5Y neurons. The compound further attenuated LPS‐induced and APPSwe plasmid‐induced reduction in SIRT1 in BV2 microglia and SH‐SY5Y, respectively. In the presence of EX527, agathisflavone lost its anti‐inflammatory and neuroprotective activities. Our results suggest that agathisflavone inhibits neuroinflammation in BV2 microglia by targeting NF‐κB signalling pathway. The compound also reduces neurotoxicity through mechanisms that are possibly linked to SIRT1 in the microglia and neurons",
keywords = "NF-κB, Agathisflavone, Anacardium occidentale, Neuroprotection, SIRT1",
author = "Ravikanth Velagapudi and Olusiji Ajileye and Okorji, {Uchechukwu P.} and Priya Jain and Mutallib Aderogba and Olumayokun Olajide",
year = "2018",
month = "10",
doi = "10.1002/ptr.6122",
language = "English",
volume = "32",
pages = "1957--1966",
journal = "Phytotherapy Research",
issn = "0951-418X",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

Agathisflavone isolated from Anacardium occidentale suppresses SIRT1‐mediated neuroinflammation in BV2 microglia and neurotoxicity in APPSwe‐transfected SH‐SY5Y cells. / Velagapudi, Ravikanth; Ajileye, Olusiji; Okorji, Uchechukwu P.; Jain, Priya; Aderogba, Mutallib; Olajide, Olumayokun.

In: Phytotherapy Research, Vol. 32, No. 10, 10.2018, p. 1957-1966.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Agathisflavone isolated from Anacardium occidentale suppresses SIRT1‐mediated neuroinflammation in BV2 microglia and neurotoxicity in APPSwe‐transfected SH‐SY5Y cells

AU - Velagapudi, Ravikanth

AU - Ajileye, Olusiji

AU - Okorji, Uchechukwu P.

AU - Jain, Priya

AU - Aderogba, Mutallib

AU - Olajide, Olumayokun

PY - 2018/10

Y1 - 2018/10

N2 - Agathisflavone is a bioactive compound in Anacardium occidentale. In this study, we investigated inhibition neuroinflammation in BV2 microglia by agathisflavone. Neuroprotective activity of the compound was investigated in differentiated SH‐SY5Y cells. Experiments in lipopolysaccharide (LPS)‐activated BV2 microglia showed that pretreatment with agathisflavone (5–20 μM) produced significant reduction in the release of tumour necrosis factor‐α, interleukin‐6, interleukin‐1β, NO, and PGE2 from the cells. Immunoblotting experiments also revealed that agathisflavone reduced levels of iNOS and COX‐2 protein. Further studies revealed that agathisflavone reduced neuroinflammation by targeting critical steps in NF‐κB signalling in BV2 microglia. Treatment of SH‐SY5Y cells with conditioned medium from LPS‐activated BV2 microglia produced a significant reduction in neuronal viability. However, conditioned medium from BV2 cells that were stimulated with LPS in the presence of agathisflavone did not induce neurotoxicity. Agathisflavone also produced neuroprotection in APPSwe plasmid‐transfected SH‐SY5Y neurons. The compound further attenuated LPS‐induced and APPSwe plasmid‐induced reduction in SIRT1 in BV2 microglia and SH‐SY5Y, respectively. In the presence of EX527, agathisflavone lost its anti‐inflammatory and neuroprotective activities. Our results suggest that agathisflavone inhibits neuroinflammation in BV2 microglia by targeting NF‐κB signalling pathway. The compound also reduces neurotoxicity through mechanisms that are possibly linked to SIRT1 in the microglia and neurons

AB - Agathisflavone is a bioactive compound in Anacardium occidentale. In this study, we investigated inhibition neuroinflammation in BV2 microglia by agathisflavone. Neuroprotective activity of the compound was investigated in differentiated SH‐SY5Y cells. Experiments in lipopolysaccharide (LPS)‐activated BV2 microglia showed that pretreatment with agathisflavone (5–20 μM) produced significant reduction in the release of tumour necrosis factor‐α, interleukin‐6, interleukin‐1β, NO, and PGE2 from the cells. Immunoblotting experiments also revealed that agathisflavone reduced levels of iNOS and COX‐2 protein. Further studies revealed that agathisflavone reduced neuroinflammation by targeting critical steps in NF‐κB signalling in BV2 microglia. Treatment of SH‐SY5Y cells with conditioned medium from LPS‐activated BV2 microglia produced a significant reduction in neuronal viability. However, conditioned medium from BV2 cells that were stimulated with LPS in the presence of agathisflavone did not induce neurotoxicity. Agathisflavone also produced neuroprotection in APPSwe plasmid‐transfected SH‐SY5Y neurons. The compound further attenuated LPS‐induced and APPSwe plasmid‐induced reduction in SIRT1 in BV2 microglia and SH‐SY5Y, respectively. In the presence of EX527, agathisflavone lost its anti‐inflammatory and neuroprotective activities. Our results suggest that agathisflavone inhibits neuroinflammation in BV2 microglia by targeting NF‐κB signalling pathway. The compound also reduces neurotoxicity through mechanisms that are possibly linked to SIRT1 in the microglia and neurons

KW - NF-κB

KW - Agathisflavone

KW - Anacardium occidentale

KW - Neuroprotection

KW - SIRT1

UR - http://www.scopus.com/inward/record.url?scp=85050816728&partnerID=8YFLogxK

U2 - 10.1002/ptr.6122

DO - 10.1002/ptr.6122

M3 - Article

VL - 32

SP - 1957

EP - 1966

JO - Phytotherapy Research

T2 - Phytotherapy Research

JF - Phytotherapy Research

SN - 0951-418X

IS - 10

ER -